IBM Forms Watson Healthcare Advisory Board

Select a topic or year

ARMONK, N.Y. - 01 Mar 2012: IBM (NYSE: IBM) today announced the formation of a new Watson Healthcare Advisory Board.  The board members include medical leaders with expertise in areas such as primary care, oncology, biomedical informatics and medical innovation. They will provide IBM with insights on healthcare issues that could be positively impacted by Watson technology adoption.

The advisory board will specifically focus on medical industry trends, clinical imperatives, regulatory considerations, privacy concerns, and patient and clinician expectations around the  Watson technology and how it can be incorporated into clinician workflows. The initial nine-member board represents leading organizations in various areas of healthcare delivery, and includes:

Watson represents a new class of industry-specific analytical solutions and decision support systems that use deep content analysis and evidence-based reasoning and natural language processing.  By accurately extracting medical facts and quickly understanding relationships buried in large volumes of data, such as electronic medical records, family medical history, and the latest clinical research, the technology can help accelerate and improve clinical decisions, reduce operational waste, and enhance patient outcomes.

"Watson represents a technology breakthrough that can help physicians improve patient outcomes," said Dr. Herbert Chase, a professor of clinical medicine at Columbia University. "As IBM focuses its efforts on key areas including oncology, cardiology and other chronic diseases, the advisory board will be integral to helping align the business strategy to the specific needs of the industry."

"The depth of leadership, talent and experience represented on the Watson Healthcare Advisory Board will be instrumental to advancing how IBM Watson technology is put to work in the healthcare industry," said Manoj Saxena, general manager of IBM Watson Solutions. "IBM's Watson technology has the potential to profoundly impact the quality of patient care by fundamentally transforming how medicine is taught, paid for and practiced."

The Watson computing technologies are currently being developed and commercialized by IBM in collaboration with the healthcare industry in order to help doctors and healthcare professionals improve diagnosis and treatment in areas such as chronic disease and oncology. 

The recommendations of the Watson Healthcare Advisory Board will be shared with IBM clients and used by IBM's global team of healthcare industry professionals. This group of more than 4,000 professionals and 60 medical doctors are working with clients to create smarter healthcare systems, focused on the patient, aimed at reducing medical errors, achieving better patient safety and quality outcomes, and saving lives. IBM has undertaken more than 3,000 healthcare transformation projects around the world from small hospitals to national healthcare systems.

About IBM

For more information about IBM Watson Solutions visit and IBM Smarter Healthcare

Related XML feeds
Topics XML feeds
Healthcare and Life Sciences
News about IBM solutions for the healthcare and life sciences industries
IBM Watson